<p>2025 年 5 月 22 日- 上午 9:07</p>
<p>1933 Industries Inc.（以下简称 “公司” 或 “1933 Industries”）（CSE:TGIF）（OTC PINK:TGIFF），一家专注于内华达州的大麻种植和生产商，欣然宣布其全资子公司 FN Pharmaceuticals 与 Caleb Zobrist 先生（以下简称 “卖方”）签订的会员权益购买协议（以下简称 “MIPA”）已被修订（请参阅 2024 年 4 月 8 日的新闻稿）。</p>
<p>根据修订后的 MIPA 条款，会员权益的购买价格（以下简称 “购买价格”）总计为 50,000 美元，卖方将获得 25,000 美元现金和 25,000 美元通过发行 1933 Industries 的普通股（以下简称 “股份”）支付。最终将向卖方发行的股份数量为 5,503,450 股，该数量是根据 2024 年 11 月 27 日的股份 10 天加权平均价格（VWAP）确定的，该日期为 MIPA 所涉及交易（以下简称 “交易”）获得内华达州大麻合规委员会批准的日期。</p>
<p>这些股份在加拿大的持有期将于 2025 年 10 月 1 日到期。根据《1933 年证券法》的规定，还将适用其他限制。</p>
<p>各方已将交易的交割日期定为 2025 年 5 月 30 日。随着 MIPA 的完成，FN Pharmaceuticals 拥有 AMA 的 100% 会员权益，该公司是公司的种植和生产子公司。</p>
<p>由于 Zobrist 先生在签订 MIPA 时是公司的高级管理人员，因此他在《多边工具 61-101 - 保护少数股东在特殊交易中的权益》（以下简称 “MI 61-101”）的意义上属于公司的 “关联方”。因此，该交易构成 MI 61-101 意义上的 “关联方交易”。</p>
<p>公司打算依赖 MI 61-101 第 5.5(a) 和 5.7(1)(a) 节中规定的正式估值和少数股东批准要求的豁免，因为该交易的公平市场价值不超过公司市值的 25%。</p>
<p><strong>关于 1933 Industries Inc.</strong></p>
<p>1933 Industries 是一家位于内华达州的持牌批发生产商，专注于在其旗舰品牌 Alternative Medicine Association（AMA）和 Level X 下，种植和提取多种格式的大麻消费产品。其产品在公司 68,000 平方英尺的室内设施中种植，并直接销售给零售药房。AMA 品牌的花卉、注入预卷烟和内部精品浓缩物始终在内华达州的销售产品中名列前茅。欲了解更多信息，请访问 www.1933industries.com</p>
<p>如需进一步信息，请联系：</p>
<p>Alexia Helgason，投资者关系副总裁</p>
<p>604-728-4407</p>
<p>alexia@1933industries.com</p>
<p>Brian Farrell，董事长兼首席执行官</p>
<p>brian@1933industries.com</p>
<p>加拿大证券交易所及其监管服务提供商（根据加拿大证券交易所政策定义的术语）对本公告的充分性或准确性不承担任何责任。</p>
<p>关于前瞻性声明的通知：本新闻稿包含前瞻性声明。使用 “预期”、“继续”、“估计”、“期望”、“可能”、“将”、“项目”、“应该”、“相信” 等词语及类似表达的目的是为了识别前瞻性声明。尽管公司相信前瞻性声明所基于的期望和假设是合理的，但不应对前瞻性声明过度依赖，因为公司无法保证这些声明将被证明是正确的。由于前瞻性声明涉及未来事件和条件，因此其本质上涉及固有的风险和不确定性。这些声明仅在本新闻稿日期有效。由于多种因素和风险，包括公司披露文件中讨论的各种风险因素，实际结果可能与当前预期有重大差异，这些文件可以在 www.sedar.com 上找到。1933 Industries 没有义务公开更新或修订任何前瞻性信息，无论是由于新信息、未来事件还是其他原因，法律要求的除外。</p>
<p><strong>来源：</strong> 1933 Industries Inc.</p>
<p>查看 ACCESS Newswire 上的原始新闻稿</p>
<p><img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTAzMDc4NQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTAzMDc4NQ"/></p>

元力控股

<p>1933 Industries Inc. 将完成对其子公司 Alternative Medicine Association LC 9% 股权的购买，总金额为 50,000 美元。付款将分为现金和股票，交易将在 2025 年 5 月 30 日完成。这项收购将使 FN Pharmaceuticals 完全拥有 AMA。由于卖方之前担任公司的高级职员，因此该交易被归类为关联方交易。公司将依赖于对正式估值和少数股东批准要求的豁免</p>

<p>05/22/2025 - 09:07 AM</p>
<div class="lb-trans"><p>2025 年 5 月 22 日- 上午 9:07</p>
</div><p>1933 Industries Inc. (the &#34;Company&#34; or &#34;1933 Industries&#34;) (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that the Membership Interest Purchase Agreement (the &#34;MIPA&#34;) entered into by its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist (the &#34;Seller&#34;) to acquire his nine percent (9%) of the issued and outstanding membership interests of Alternative Medicine Association LC (&#34;AMA&#34;) has been amended (refer to news release dated April 8, 2024).</p>
<div class="lb-trans"><p>1933 Industries Inc.（以下简称 “公司” 或 “1933 Industries”）（CSE:TGIF）（OTC PINK:TGIFF），一家专注于内华达州的大麻种植和生产商，欣然宣布其全资子公司 FN Pharmaceuticals 与 Caleb Zobrist 先生（以下简称 “卖方”）签订的会员权益购买协议（以下简称 “MIPA”）已被修订（请参阅 2024 年 4 月 8 日的新闻稿）。</p>
</div><p>Under the amended terms of the MIPA, the purchase price (the &#34;Purchase Price&#34;) for the Membership is a total of USD$50,00, payable to the Seller USD$25,000 in cash and USD$25,000 through the issuance of shares of common stock of 1933 Industries (the &#34;Shares&#34;). The final number of Shares to be issued to the Seller is 5,503,450 as determined via the 10 day VWAP price of the Shares on November 27, 2024, being the date the transactions contemplated by the MIPA (the &#34;Transaction&#34;) were approved by the Nevada Cannabis Compliance Board.</p>
<div class="lb-trans"><p>根据修订后的 MIPA 条款，会员权益的购买价格（以下简称 “购买价格”）总计为 50,000 美元，卖方将获得 25,000 美元现金和 25,000 美元通过发行 1933 Industries 的普通股（以下简称 “股份”）支付。最终将向卖方发行的股份数量为 5,503,450 股，该数量是根据 2024 年 11 月 27 日的股份 10 天加权平均价格（VWAP）确定的，该日期为 MIPA 所涉及交易（以下简称 “交易”）获得内华达州大麻合规委员会批准的日期。</p>
</div><p>The Shares are subject to a hold period in Canada expiring on October 1, 2025. Additional restrictions will apply pursuant to the Securities Act of 1933, as amended.</p>
<div class="lb-trans"><p>这些股份在加拿大的持有期将于 2025 年 10 月 1 日到期。根据《1933 年证券法》的规定，还将适用其他限制。</p>
</div><p>The parties have set the closing date for the Transaction as May 30, 2025. With the completion of the MIPA, FN Pharmaceuticals owns 100% of the membership interest in AMA, the Company's cultivation and production subsidiary.</p>
<div class="lb-trans"><p>各方已将交易的交割日期定为 2025 年 5 月 30 日。随着 MIPA 的完成，FN Pharmaceuticals 拥有 AMA 的 100% 会员权益，该公司是公司的种植和生产子公司。</p>
</div><p>As Mr. Zobrist was a senior officer of the Company at the time the MIPA was entered into, he is a &#34;related party&#34; to the Company within the meaning of Multilateral Instrument 61-101- Protection of Minority Security Holders in Special Transactions (&#34;MI 61-101&#34;). As such, the transaction constitutes a &#34;related party transaction&#34; within the meaning of MI 61-101.</p>
<div class="lb-trans"><p>由于 Zobrist 先生在签订 MIPA 时是公司的高级管理人员，因此他在《多边工具 61-101 - 保护少数股东在特殊交易中的权益》（以下简称 “MI 61-101”）的意义上属于公司的 “关联方”。因此，该交易构成 MI 61-101 意义上的 “关联方交易”。</p>
</div><p>The Company intends to rely on exemptions from formal valuation and the minority shareholder approval requirements of MI 61-101 found in sections 5.5(a) and 5.7(1)(a) of MI 61-101 as the fair market value of the transaction does not constitute more than the 25% of the Company's market capitalization.</p>
<div class="lb-trans"><p>公司打算依赖 MI 61-101 第 5.5(a) 和 5.7(1)(a) 节中规定的正式估值和少数股东批准要求的豁免，因为该交易的公平市场价值不超过公司市值的 25%。</p>
</div><p><strong>About 1933 Industries Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 1933 Industries Inc.</strong></p>
</div><p>1933 Industries is a Nevada-based licensed wholesale producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company's 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com</p>
<div class="lb-trans"><p>1933 Industries 是一家位于内华达州的持牌批发生产商，专注于在其旗舰品牌 Alternative Medicine Association（AMA）和 Level X 下，种植和提取多种格式的大麻消费产品。其产品在公司 68,000 平方英尺的室内设施中种植，并直接销售给零售药房。AMA 品牌的花卉、注入预卷烟和内部精品浓缩物始终在内华达州的销售产品中名列前茅。欲了解更多信息，请访问 www.1933industries.com</p>
</div><p>For further information please contact:</p>
<div class="lb-trans"><p>如需进一步信息，请联系：</p>
</div><p>Alexia Helgason, VP, Investor Relations</p>
<div class="lb-trans"><p>Alexia Helgason，投资者关系副总裁</p>
</div><p>604-728-4407</p>
<div class="lb-trans"><p>604-728-4407</p>
</div><p>alexia@1933industries.com</p>
<div class="lb-trans"><p>alexia@1933industries.com</p>
</div><p>Brian Farrell, Chairman and CEO</p>
<div class="lb-trans"><p>Brian Farrell，董事长兼首席执行官</p>
</div><p>brian@1933industries.com</p>
<div class="lb-trans"><p>brian@1933industries.com</p>
</div><p>Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大证券交易所及其监管服务提供商（根据加拿大证券交易所政策定义的术语）对本公告的充分性或准确性不承担任何责任。</p>
</div><p>Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words &#34;anticipate&#34;, &#34;continue&#34;, &#34;estimate&#34;, &#34;expect&#34;, &#34;may&#34;, &#34;will&#34;, &#34;project&#34;, &#34;should&#34;, &#34;believe&#34; and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.</p>
<div class="lb-trans"><p>关于前瞻性声明的通知：本新闻稿包含前瞻性声明。使用 “预期”、“继续”、“估计”、“期望”、“可能”、“将”、“项目”、“应该”、“相信” 等词语及类似表达的目的是为了识别前瞻性声明。尽管公司相信前瞻性声明所基于的期望和假设是合理的，但不应对前瞻性声明过度依赖，因为公司无法保证这些声明将被证明是正确的。由于前瞻性声明涉及未来事件和条件，因此其本质上涉及固有的风险和不确定性。这些声明仅在本新闻稿日期有效。由于多种因素和风险，包括公司披露文件中讨论的各种风险因素，实际结果可能与当前预期有重大差异，这些文件可以在 www.sedar.com 上找到。1933 Industries 没有义务公开更新或修订任何前瞻性信息，无论是由于新信息、未来事件还是其他原因，法律要求的除外。</p>
</div><p><strong>SOURCE:</strong> 1933 Industries Inc.</p>
<div class="lb-trans"><p><strong>来源：</strong> 1933 Industries Inc.</p>
</div><p>View the original press release on ACCESS Newswire</p>
<div class="lb-trans"><p>查看 ACCESS Newswire 上的原始新闻稿</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTAzMDc4NQ" alt="" original-src="https://app.accessnewswire.com/img.ashx?id=1030785"/></p>

1933 Industries 将完成收购其种植和生产子公司 9% 股权的交易 | TGIFF 股票新闻